Calamos Advisors’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13	Closed	-$258K	–	1182
2022 Q4	$258K	Hold	13	–	–	﹤0.01%	909
2022 Q3	$253K	Buy	+13	New	+$253K	﹤0.01%	1009